{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:06:47Z","timestamp":1780038407670,"version":"3.53.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.critrevonc.2026.105351","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:08:55Z","timestamp":1777579735000},"page":"105351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Invisible signals, visible dilemmas: The ethical frontiers of liquid biopsy in precision oncology"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0257-7439","authenticated-orcid":false,"given":"Bibek","family":"Aryal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munekazu","family":"Yamakuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruto","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2026.105351_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/annonc\/mdy552","article-title":"Clonal haematopoiesis: a source of biological noise in cell-free DNA analyses","volume":"30","author":"Abbosh","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105351_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100165","article-title":"Global landscape of liquid biopsy research: regional contributions and disparities","volume":"6","author":"Abdelwahab","year":"2024","journal-title":"J. Liq. Biopsy"},{"key":"10.1016\/j.critrevonc.2026.105351_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bas.2024.102817","article-title":"Limitless potential within limited resources: The realm of liquid biopsy for brain tumors in low-middle-income countries","volume":"4","author":"Ahmad","year":"2024","journal-title":"Brain Spine"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105351_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/2159-8290.CD-20-1311","article-title":"Liquid biopsy: from discovery to clinical application","volume":"11","author":"Alix-Panabi\u00e8res","year":"2021","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12672-025-02064-7","article-title":"AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis","volume":"16","author":"Alum","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12911-020-01332-6","article-title":"Madai VI, Precise4Q consortium. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective","volume":"20","author":"Amann","year":"2020","journal-title":"BMC Med Inf. Decis. Mak."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105351_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3917\/jib.283.0113","article-title":"WMA Declaration of Taipei on ethical considerations regarding health databases and biobanks: adopted by the 53 rd WMA General Assembly, Washington, DC, USA, October 2002 and revised by the 67 th WMA General Assembly, Taipei, Taiwan, October 2016","volume":"28","author":"Annexe 2","year":"2017","journal-title":"J. Int. De. bio\u00e9thique Et. D. \u2019\u00e9thique Des. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105351_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/cancers16040760","article-title":"Navigating precision oncology: insights from an integrated clinical data and biobank repository initiative across a network cancer program","volume":"16","author":"Aryal","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105351_bib9","article-title":"Deciphering platelet kinetics in diagnostic and prognostic evaluation of hepatocellular Carcinoma","volume":"2018","author":"Aryal","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/CBM-190168","article-title":"Bivalent property of intra-platelet VWF in liver regeneration and HCC recurrence: a prospective multicenter study","volume":"26","author":"Aryal","year":"2019","journal-title":"Cancer Biomark."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105351_bib11","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","article-title":"RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics","volume":"28","author":"Best","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105351_bib12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41588-020-0651-0","article-title":"Privacy challenges and research opportunities for genomic data sharing","volume":"52","author":"Bonomi","year":"2020","journal-title":"Nat. Genet"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105351_bib13","doi-asserted-by":"crossref","first-page":"e1371","DOI":"10.1634\/theoncologist.2019-0057","article-title":"Delays and barriers to cancer care in low- and middle-income countries: a systematic review","volume":"24","author":"Brand","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12910-016-0162-9","article-title":"Dynamic Consent: a potential solution to some of the challenges of modern biomedical research","volume":"18","author":"Budin-Lj\u00f8sne","year":"2017","journal-title":"BMC Med Ethics"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105351_bib15","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.3390\/app15126578","article-title":"From genomics to AI: revolutionizing precision medicine in oncology","volume":"15","author":"Calvino","year":"2025","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.37349\/etat.2023.00125","article-title":"Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer","volume":"4","author":"Caputo","year":"2023","journal-title":"Explor Target Antitumor Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jlb\/lst004","article-title":"A review of the key issues associated with the commercialization of biobanks","volume":"1","author":"Caulfield","year":"2014","journal-title":"J. Law Biosci."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105351_bib18","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/cancers12082277","article-title":"Clonal hematopoiesis in liquid biopsy: from biological noise to valuable clinical implications","volume":"12","author":"Chan","year":"2020","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105351_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.45050","article-title":"Guiding principles to address the impact of algorithm bias on racial and ethnic disparities in health and health care","volume":"6","author":"Chin","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2026.105351_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100296","article-title":"Circulating miRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis","volume":"8","author":"Cicatiello","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105351_bib21","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.3390\/ijms26115013","article-title":"Liquid biopsy: the challenges of a revolutionary approach in oncology","volume":"26","author":"Coppola","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105351_bib22","series-title":"International Ethical Guidelines for Health\u2011related Research Involving Humans. 4th ed","author":"Council for International Organizations of Medical Sciences","year":"2016"},{"key":"10.1016\/j.critrevonc.2026.105351_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100310","article-title":"Liquid biopsy: current advancements in clinical practice for bladder cancer","volume":"9","author":"Crocetto","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105351_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000651","article-title":"Bias in medical AI: implications for clinical decision-making","volume":"3","author":"Cross","year":"2024","journal-title":"PLOS Digit Health"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105351_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105351_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154941","article-title":"Circulating tumor DNA: current challenges for clinical utility","volume":"132","author":"Dang","year":"2022","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.critrevonc.2026.105351_bib27","unstructured":"Definition of liquid biopsy - NCI Dictionary of Cancer Terms - NCI [Internet]. [cited 2025 Jul 30]. Available from: \u3008https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/liquid-biopsy\u3009."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105351_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2020.7542","article-title":"Private payer and medicare coverage for circulating tumor DNA testing: a historical analysis of coverage policies from 2015 to 2019","volume":"18","author":"Douglas","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.36401\/JIPO-20-26","article-title":"Real-world data on liquid biopsy use in non-small cell lung cancer in the community setting","volume":"4","author":"Dvir","year":"2021","journal-title":"J. Immunother. Precis Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105351_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/18758592241297849","article-title":"Multi-cancer early detection tests: attributes for clinical implementation","volume":"42","author":"Ebbert","year":"2025","journal-title":"Cancer Biomark."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105351_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032939","article-title":"CtDNA\u2019s prognostic value in patients with early-stage colorectal cancer after surgery: a meta-analysis and systematic review","volume":"102","author":"Fan","year":"2023","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105351_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/PO.23.00382","article-title":"Recommendations for the equitable and widespread implementation of liquid biopsy for cancer care","author":"Febbo","year":"2024","journal-title":"JCO Precis Oncol."},{"issue":"16_","key":"10.1016\/j.critrevonc.2026.105351_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1200\/JCO.2025.43.16_suppl.555","article-title":"Real-world (rw) ctDNA testing trends and associated outcomes in patients (pts) with early stage breast cancer (EBC)","volume":"43","author":"Fidyk","year":"2025","journal-title":"JCO"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105351_bib34","first-page":"479","article-title":"BloodPAC data commons for liquid biopsy data","author":"Grossman","year":"2021","journal-title":"JCO Clin. Cancer Inf."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105351_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.23186","article-title":"Trends and disparities in next-generation sequencing in metastatic prostate and urothelial cancers","volume":"7","author":"Hage Chehade","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105351_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100686","article-title":"Ethical and bias considerations in artificial intelligence\/machine learning","volume":"38","author":"Hanna","year":"2025","journal-title":"Mod. Pathol."},{"issue":"34","key":"10.1016\/j.critrevonc.2026.105351_bib37","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1200\/JCO.22.01113","article-title":"A process framework for ethically deploying artificial intelligence in oncology","volume":"40","author":"Hantel","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105351_bib38","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3390\/ijerph19052598","article-title":"The role of medical mistrust in concerns about tumor genomic profiling among black and African American Cancer Patients","volume":"19","author":"Hoadley","year":"2022","journal-title":"Int J. Environ. Res Public Health"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105351_bib39","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1200\/JCO.22.00796","article-title":"Yes, we can, but should we? Ethical considerations in reporting germline findings from paired tumor-normal genomic testing in patients with advanced cancer","volume":"41","author":"Hunter","year":"2023","journal-title":"JCO"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105351_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic - implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105351_bib41","doi-asserted-by":"crossref","unstructured":"Imai M., Sakashita S., Yuda J., Kobayashi S., Yamashita R., Hashimoto T., et al. SCRUM-Japan MONSTAR-SCREEN-3: Comprehensive tumor microenvironment analysis via multi-omics in a large-scale prospective study. JCO [Internet]. 2025 Jun [cited 2025 Jul 30];43(16_suppl). Available from: \u3008https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2025.43.16_suppl.TPS3170\u3009.","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS3170"},{"issue":"6352","key":"10.1016\/j.critrevonc.2026.105351_bib42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1126\/science.aam9710","article-title":"Deriving genomic diagnoses without revealing patient genomes","volume":"357","author":"Jagadeesh","year":"2017","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105351_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101346","article-title":"Insights into post-marketing clinical validation of companion diagnostics with reference to the FDA, EMA, PMDA, and MFDS","volume":"32","author":"Kang","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2026.105351_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/15562646211055282","article-title":"Biobank participants\u2019 attitudes toward data sharing and privacy: the role of trust in reducing perceived risks","volume":"17","author":"Kasperbauer","year":"2022","journal-title":"J. Empir. Res. Hum. Res. Ethics"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105351_bib45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105351_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037154","article-title":"Closing the diagnostic gap: liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa","volume":"103","author":"Kokori","year":"2024","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/17470161241278064","article-title":"A rapid review of the benefits and challenges of dynamic consent","volume":"21","author":"Lay","year":"2025","journal-title":"Res. Ethics"},{"key":"10.1016\/j.critrevonc.2026.105351_bib48","unstructured":"List of Cleared or Approved Companion Diagnostic Devices (In Vitro and Imaging Tools) | FDA [Internet]. [cited 2025 Jul 30]. Available from: \u3008https:\/\/www.fda.gov\/medical-devices\/in-vitro-diagnostics\/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools\u3009."},{"issue":"6538","key":"10.1016\/j.critrevonc.2026.105351_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw3616","article-title":"Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies","volume":"372","author":"Lo","year":"2021","journal-title":"Science"},{"issue":"16_","key":"10.1016\/j.critrevonc.2026.105351_bib50","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1200\/JCO.2023.41.16_suppl.3047","article-title":"Molecular profiling of ctDNA from NCI-MATCH patients enrolled for treatment with mTOR1\/2 inhibitor sapanisertib (arm M) and the Hedgehog pathway inhibitor vismodegib (arm T)","volume":"41","author":"LoCoco","year":"2023","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105351_bib51","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/cancers12040776","article-title":"Biobanking in molecular biomarker research for the early detection of cancer","volume":"12","author":"Lommen","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib53","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1159\/000535174","article-title":"False-positive liquid biopsy assays secondary to overlapping aberrant methylation from non-cancer disease states","volume":"16","author":"Lutfi","year":"2023","journal-title":"Case Rep. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib54","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib55","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41746-025-01732-w","article-title":"Identifying and mitigating algorithmic bias in the safety net","volume":"8","author":"Mackin","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.critrevonc.2026.105351_bib56","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1016\/j.annonc.2025.08.1298","article-title":"723O Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients: Final results of the PEGASUS trial","volume":"36","author":"Marsoni","year":"2025","journal-title":"Ann. Oncol."},{"issue":"16_","key":"10.1016\/j.critrevonc.2026.105351_bib57","article-title":"Cost-effectiveness of targeted vs. multi-cancer blood tests for colorectal cancer","volume":"42","author":"Meester","year":"2024","journal-title":"JCO"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105351_bib58","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"36","author":"Merker","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib59","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1038\/s41467-025-58465-3","article-title":"The Estonian Biobank\u2019s journey from biobanking to personalized medicine","volume":"16","author":"Milani","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105351_bib60","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat. Med"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105351_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000278","article-title":"Bias in artificial intelligence algorithms and recommendations for mitigation","volume":"2","author":"Nazer","year":"2023","journal-title":"PLOS Digit Health"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib62","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-025-03929-y","article-title":"Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults","volume":"23","author":"Nguyen","year":"2025","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105351_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004099","article-title":"Time to end parachute science","volume":"19","author":"Odeny","year":"2022","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105351_bib64","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s41591-024-03081-9","article-title":"Building genomic capacity for precision health in Africa","volume":"30","author":"Olono","year":"2024","journal-title":"Nat. Med"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105351_bib65","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","article-title":"ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group","volume":"33","author":"Pascual","year":"2022","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib66","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1038\/s41467-022-33407-5","article-title":"Federated learning enables big data for rare cancer boundary detection","volume":"13","author":"Pati","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib67","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12910-022-00848-y","article-title":"Ownership of individual-level health data, data sharing, and data governance","volume":"23","author":"Piasecki","year":"2022","journal-title":"BMC Med Ethics"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105351_bib68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/medethics-2018-105258","article-title":"The biobank consent debate: why \u201cmeta-consent\u201d is still the solution!","volume":"45","author":"Ploug","year":"2019","journal-title":"J. Med Ethics"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105351_bib69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.amjmed.2024.10.023","article-title":"Are blood-based cancer screening tests ready for primetime?","volume":"138","author":"Prasad","year":"2025","journal-title":"Am. J. Med"},{"key":"10.1016\/j.critrevonc.2026.105351_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1272924","article-title":"Introducing dynamic consent for improved trust and privacy in research involving human biological material and associated data in South Africa","volume":"15","author":"Prinsen","year":"2024","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib71","article-title":"African genomic data sharing and the struggle for equitable benefit","volume":"3","author":"Ramsay","year":"2022","journal-title":"Patterns (N. Y)"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105351_bib72","article-title":"GA4GH: International policies and standards for data sharing across genomic research and healthcare","volume":"1","author":"Rehm","year":"2021","journal-title":"Cell Genom."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105351_bib73","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1158\/1078-0432.CCR-23-3321","article-title":"Measurement of ctDNA tumor fraction identifies informative negative liquid biopsy results and informs value of tissue confirmation","volume":"30","author":"Rolfo","year":"2024","journal-title":"Clin. Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105351_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70641","article-title":"Health economic evaluations of circulating tumor DNA testing for cancer screening: systematic review","volume":"14","author":"Rui","year":"2025","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12672-025-01940-6","article-title":"Beyond traditional biopsies: the emerging role of ctDNA and MRD on breast cancer diagnosis and treatment","volume":"16","author":"Sabit","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib76","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41746-024-01221-6","article-title":"Mapping the regulatory landscape for artificial intelligence in health within the European Union","volume":"7","author":"Schmidt","year":"2024","journal-title":"NPJ Digit Med"},{"issue":"10409","key":"10.1016\/j.critrevonc.2026.105351_bib77","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105351_bib78","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/GIM.0b013e31821d2f88","article-title":"Active choice but not too active: public perspectives on biobank consent models","volume":"13","author":"Simon","year":"2011","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005924","article-title":"Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy","volume":"11","author":"Sivapalan","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"4_","key":"10.1016\/j.critrevonc.2026.105351_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1200\/JCO.2025.43.4_suppl.275","article-title":"Identifying the optimal post-surgical timing of molecular residual disease (MRD) detection in colorectal cancer (CRC) using an ultra-sensitive assay: Interim results from the VICTORI study","volume":"43","author":"Solar Vasconcelos","year":"2025","journal-title":"JCO"},{"key":"10.1016\/j.critrevonc.2026.105351_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104613","article-title":"Liquid biopsy entering clinical practice: past discoveries, current insights, and future innovations","volume":"207","author":"Song","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105351_bib82","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1377\/hlthaff.2018.0159","article-title":"Encouraging participation and transparency in biobank research","volume":"37","author":"Spector-Bagdady","year":"2018","journal-title":"Health Aff."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105351_bib83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ejhg.2012.282","article-title":"Broad consent versus dynamic consent in biobank research: is passive participation an ethical problem?","volume":"21","author":"Steinsbekk","year":"2013","journal-title":"Eur. J. Hum. Genet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib84","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12911-017-0494-5","article-title":"Security controls in an integrated Biobank to protect privacy in data sharing: rationale and study design","volume":"17","author":"Takai-Igarashi","year":"2017","journal-title":"BMC Med Inf. Decis. Mak."},{"key":"10.1016\/j.critrevonc.2026.105351_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1612376","article-title":"Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions","volume":"12","author":"Thalambedu","year":"2025","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105351_bib86","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41591-025-04030-w","article-title":"Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2\/3 DYNAMIC-III trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hast.115","article-title":"Respecting donors to biobank research","volume":"43","author":"Tomlinson","year":"2013","journal-title":"Hastings Cent. Rep."},{"key":"10.1016\/j.critrevonc.2026.105351_bib88","doi-asserted-by":"crossref","unstructured":"Turner N.C., Mayer E.L., Park Y.H., Janni W., Ma C.X., Cristofanilli M., et al. Camizestrant + CDK4\/6 inhibitor (CDK4\/6i) for the treatment of emergent ESR1 mutations during first-line (1L) endocrine-based therapy (ET) and ahead of disease progression in patients (pts) with HR+\/HER2\u2013 advanced breast cancer (ABC): Phase 3, double-blind ctDNA-guided SERENA-6 trial. JCO [Internet]. 2025 Jun 10 [cited 2025 Jul 30];43(17_suppl). Available from: \u3008https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2025.43.17_suppl.LBA4\u3009.","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA4"},{"key":"10.1016\/j.critrevonc.2026.105351_bib89","series-title":"Artificial Intelligence\/Machine Learning (AI\/ML)-Based Software as a Medical Device (SaMD) Action Plan [Internet]","author":"U.S. Food and Drug Administration","year":"2021"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105351_bib90","first-page":"137","article-title":"Privacy-preserving data sharing for genome-wide association studies","volume":"5","author":"Uhlerop","year":"2013","journal-title":"J. Priv. Confid."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105351_bib91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11019-022-10074-3","article-title":"Evaluating models of consent in changing health research environments","volume":"25","author":"Wiertz","year":"2022","journal-title":"Med Health Care Philos."},{"key":"10.1016\/j.critrevonc.2026.105351_bib92","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.2147\/RMHP.S450082","article-title":"Paradigm transformation of global health data regulation: challenges in governance and human rights protection of cross-border data flows","volume":"17","author":"Xia","year":"2024","journal-title":"Risk Manag Health Policy"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:57:14Z","timestamp":1780037834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":92,"alternative-id":["S1040842826002386"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105351","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invisible signals, visible dilemmas: The ethical frontiers of liquid biopsy in precision oncology","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105351"}}